| PROTARA THERAPEUT.DL-,001 |
| USA |
| Gesundheit |
| US74365U1079 / A2P4JE |
| 1KPA (Frankfurt) / TARA (NASDAQ) |
| FRA:1KPA, ETR:1KPA, 1KPA:GR, NASDAQ:TARA |
| - |
| https://protaratx.com/ |
|
Protara Therapeutics Inc. is a biotechnology company focused on developing transformative therapies for rare and speciality diseases. The company's primary function is to innovate treatment solutions ..
>Volltext.. |
| 277.95 Mio. EUR |
| 168.18 Mio. EUR |
| - |
| -50.3 Mio. EUR |
| -44.78 Mio. EUR |
| -1.22 EUR |
| 3.09 Mio. EUR |
| 10.62 Mio. EUR |
| -41.24 Mio. EUR |
| 13.39 |
| - |
| -19.37% |
| - |
| - |
| - |
| - |
| PROTARA |
| 02.03.26 |
|